19 December 2019
Visiongain’s new report the Ambulance & Medical Transport Market Report 2019-2029 : Forecasts by Type (Medical Products Transport, Mobile Treatment Facilities, Patient Transport, Incubator Transport), by End User (Hospitals, Nursing Care Facilities, Medical Centers, Private Paying Customers), plus analysis of leading companies indicates that the global Ambulance & Medical Transport market will attain $59 billion revenue by 2029.
Global Ambulance & Medical Transport market is expected to grow on account of increasing number of medical complication in the population. The market is expected to grow at a healthy CAGR of 6.3% over the projected period. Ambulance and medical transportation relates to medical equipment that promotes patient care during medical emergencies, such as accidents and surgery, helps avoid life loss, and minimizes personal injury. Technological progress, rising incidence of accidents, and growing population ageing are some of the primary factors driving the market for ambulance and medical transport.
Transport services in the healthcare industry act as an assistance to guarantee secure and timely transfer from one place to another of patients, medications, medical equipment and test specimens. This, in turn, improves the healthcare sector's effectiveness. The segment of patient transport is expected to account for most market share and is projected to develop at a greater pace driven by increasing emphasis on enhancing the value chain in the healthcare industry.
In 2019, North America accounted for more than 35% of overall ambulance and medical transport demand and increasing prevalence of chronic diseases, growing healthcare expenditure, and advanced healthcare infrastructure in this region is expected to strengthen Ambulance & Medical Transport market concentration in North America over the projected period. Asia Pacific region is anticipated to witness fastest growth rate in the ambulance and medical transportation industry in the coming years due to growing health infrastructure, increased accident prevalence, increased disposable income, increased incidence of multiple illnesses, increased elderly population, and increased awareness of emergency medical transportation services available on the market.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to firstname.lastname@example.org or call her on +44 (0) 207 336 6100.
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
Penicillin segment holds majority of the market share owing to maximum prescription as well as the most generic manufacturers throughout the industry.
22 June 2021
Over the last few years, companion diagnostics has gained widespread attention due to the technological advancements, growing demand for precision medicine, and accelerating demand for targeted therapy.
17 June 2021
Increasing prevalence of cancers and rising demand for advanced therapies for cancer treatment are the major factors driving the demand for cellular immunotherapies.
15 June 2021
Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions.